Zerenex ferric citrate: Phase II started

Keryx began a placebo-controlled, U.S. Phase II trial to evaluate Zerenex for 12 weeks in about 150 anemic patients with stage III-V non-dialysis dependent CKD. The compound is in Phase III testing to...